Inhibition of cell growth and apoptosis by inducible expression of the transcriptional repressor Mad1

Experimental Cell Research

Volumn 260, Issue 1, 2000, Pages 61-72

  Bejarano, Maria Teresa ^a   Albihn, Ami ^a   Cornvik, Tobias ^a   Brijker, Susanne Osterdahl ^a   Asker, Charlotte ^a   Osorio, Lyda M ^a   Henriksson, Marie ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Apoptosis; Cell cycle; Cell growth; Mad1

Indexed keywords

CISPLATIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOXYCYCLINE; HISTONE DEACETYLASE; PROTEIN MAD1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN 3T3; CONTROLLED STUDY; CULTURE MEDIUM; DNA CONTENT; ENZYME ACTIVITY; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REPRESSOR GENE; WESTERN BLOTTING;

EID: 0034634001     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4996     Document Type: Article

References (62)

1. Proteins of the Myc network: Essential regulators of cell growth and differentiation
2. Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity
3. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites
4. Mad3 and Mad4: Novel Max-interacting transcriptional repressors that suppress c-Myc-dependent transformation and are expressed during neural and epidermal differentiation
5. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites
6. Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor
7. Myc family oncogenes in the development of normal and neoplastic cells
8. Myc function and regulation
9. A switch from Myc: Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation
10. Expression of mad, mxi1, max and c-myc during differentiation of hematopoietic cells: Opposite regulation of mad and c-myc
11. Contrasting roles for Myc and Mad proteins in cellular growth and differentiation
12. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis
13. Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro
14. Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity
15. Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1
16. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins
17. Mad repression of Myc-Ras cotransformation is mediated by multiple protein-protein interactions
18. Effects of the Myc oncogene antagonist, Mad, on proliferation, cell cycling and the malignant phenotype of human brain tumor cells
19. Inducible expression of Mad accelerates growth arrest of serum deprived human glioblastoma cells
20. Inhibition of cell proliferation by the Mad1 transcriptional repressor
21. Mad:Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of the yeast repressor Sin3
22. An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3
23. Mad proteins contain a dominant transcription repression domain
24. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1
25. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression
26. Histone deacetylase activity is required for full transcriptional repression by mSin3A
27. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression
28. Histone deacetylases associated with the mSin3 corepressor mediate Mad transcriptional repression
29. Sinful repression
30. Function of the c-Myc antagonist Mad1 during a molecular switch from proliferation to differentiation
31. Targeted disruption of the Myc antagonist Mad1 inhibts cell cycle exit during granulocyte differentiation
32. Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth
33. The structure and nucleotide sequence of the 5' end of the human c-myc oncogene
34. High efficiency DNA-mediated transformation of primate cells
35. High-efficiency transformation of mammalian cells by plasmid DNA
36. Transcriptional activation by tetracyclines in mammalian cells
37. Chimaeras of Myc oncoprotein and steroid receptors cause transformation of cells
38. Induction of apoptosis in fibroblasts by c-Myc protein
39. Tumor suppression at the mouse INK4a locus mediated by the alternative reading flame product p19(ARF)
40. Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes
41. Myc activation of cyclinE/cdk2 kinase involves induction of cyclin E transcription and inhibition of p27Kip1 binding to newly formed complexes
42. Activation of c-Myc uncouples DNA replication from activation of G1-cyclin-dependent kianses
43. Myc and the cell cycle
44. Mysterious liasions: The relationship between c-Myc and the cell cycle
45. Traps to catch unwary oncogenes
46. Apoptotic cell death induced by c-myc is inhibited by bcl-2
47. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines
48. Cooperative interaction between c-myc and bcl-2 proto-oncogenes
49. Inhibition of proliferation and apoptosis by the transcriptional repressor Mad1
50. p27 Kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest
51. Cloning of p27Kip, a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals
52. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice
53. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27 (Kip1)
54. Mice lacking p27 (Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors
55. Growth arrest by the cyclin-dependent kinase inhibitor p27(Kip1) is abrogated by c-Myc
56. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclinE/cdk2 complexes
57. c-Myc regulates cyclin D-cdk4 and -cdk6 activity but affects cell cycle progression at multiple independent points
58. Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclinE/CDK2 kinase activity
59. Dwarfism and dysregulated proliferation in mice overexpressing the Myc antagonist Mad1
60. The Myc oncoprotein: A critical evaluation of transactivation and target gene regulation
61. Mechanisms of apoptosis of c-Myc
62. Identification and characterization of specific DNA-binding complexes containing members of the Myc/Max/Mad network of transcriptional regulators